Fabienne Hartmann-Fritsch
Co-Project Leader and Clinical Trial Manager


Fabienne Hartmann-Fritsch joined Wyss Zurich in October 2016. She is responsible for the project leadership and the clinical trial management for the clinical trials with the personalized skin graft “denovoSkin”. In addition, she actively supports the GMP-production of the skin grafts. Fabienne received her MSc in Microbiology and Immunology from the ETH Zurich in 2008 and her PhD in Biology from the University of Zurich in 2013. During her postdoctoral studies at the Tissue Biology Research Unit of the University Children’s Hospital Zurich she specialized on GMP-production of human skin grafts as well as on clinical trial management and regulatory affairs.


Daniela Marino
Co-Project Leader and Business Developer


Daniela Marino is responsible for the development of personalized skin grafts for the treatment of skin defects. Daniela received her MSc in Biotechnologies from the University of Milan in 2005 and her PhD from the Institute of Pharmacological Sciences of ETH Zurich in 2009. During her postdoctoral studies at the Tissue Biology Research Unit in Zurich, she specialized in tissue engineering of skin, and also gained expertise in project management, product development, clinical trials and regulatory affairs. She is a co-founder of the UZH spin-off CUTISS AG, awarded with the Venture Best Business Plan prize in 2015. Her professional mission is to finally provide a real solution to patients suffering from skin defects.


Get to know the entire team behind denovoSkin on the website of CUTISS AG.

09-09-21 - Event

The Top 100 Startup Award 2021 - Numerous Wyss Zurich projects under the Top 100 Startups 2021
read more

02-07-21 - News

BURNS OPEN - Further proof of principle for denovoSkin on a massive burn with a one-year follow-up
read more

24-06-21 - Press Release

CUTISS develops world`s first machine to produce personalized human tissue
read more

25-05-21 - Media Coverage

startupticker.ch - CUTISS´denovoSkin first large scale transplantation delivers proof of principle
read more

More News